Duncan Hall looks back at an interesting year for RBQM, and makes some predictions for 2021.

Who do you trust to help you with your Risk Based Quality Management? How do you build and develop trust in a virtual world where the traditional methods have gone? Where you can't sit face-to-face, chat over a coffee, look someone directly in the eye when you ask them a direct question, and shake hands on a deal? How do you know you can trust your RBQM partner when things go wrong (and they will because that's life)?

A framework for successfully managing change in your organisation.

How to reduce the fragility of your clinical trials to make them less vulnerable to risks, including future pandemics and the resurgence of COVID-19.

Clinical trial Risk Management is a multi-dimensional problem. Six dimensions to be exact. That being the case, why do people insist on trying to use a 2-dimensional tool (Excel)? Because it's easy to get started? Yes it is. But it very quickly becomes unwieldy and errors creep in. Once you understand the multi-dimensional nature of risk management, it becomes obvious why Excel isn't up to the job. You need something better. In this webinar, Duncan will take you through the set-up of a Protocol Risk Assessment covering each of the six dimensions, why they're so important and how they are handled in our industry-leading Risk Assessment and Management tool, OPRA.

How do you organize your structures, processes, tools and technology to set your trial up for success? In the fifth webinar in the series, Duncan will show you the benefits of Integrated Strategic Monitoring Planning linked to remote and central monitoring on your trials.

In this webinar, the fourth in the series of 9 COVID-19 related webinars, Duncan takes you through Risk Assessment and Management best practice, and explains why Risk Management is a multi-dimensional problem and therefore why Excel is the wrong tool for the job. He also makes an offer for people to try TRI's Risk Assessment and Management tool (OPRA)

COVID-19 has forced us to do things differently. How do we do more with less and improve the way we run our clinical trials forever? In the third webinar in the series, Duncan will discuss what ‘right-sizing’ means for different organisations and looks at what‘s critical and what’s possible in the future.